Neuroscience
6 N,n' Dimethylarginine
5%
Acetylcholine
6%
Adenosine
5%
Agonist
20%
Alzheimer's Disease
100%
Amnesia
9%
Amyloid
27%
Anti-Inflammatory
15%
Antiporter
12%
Aspartic Acid
20%
Astrocyte
13%
Behavior (Neuroscience)
23%
Beta Amyloid
22%
Brain Ischemia
8%
Brain Metabolism
7%
Calcium Channel
8%
Cell Death
17%
Cell Loss
8%
Cell Maturation
5%
Cell Signaling
17%
Central Nervous System
12%
Cerebellum
5%
Cholinergic
11%
Cognitive Disorders
16%
Cognitive Function
6%
CXCL10
5%
Cyclic Adenosine Monophosphate
19%
Cyclic AMP Dependent Protein Kinase Anchoring Protein
11%
Cyclic Peptide
5%
Depression
10%
Eicosanoid Receptor
15%
Electroconvulsive Therapy
14%
Encephalopathy
13%
Endoplasmic reticulum
7%
Excitotoxicity
11%
Fear Conditioning
9%
Ferroptosis
6%
Glutamic Acid
18%
Granule Cell
5%
Hippocampus
11%
Hyperphosphorylation
7%
Hypothermia
6%
In Vitro
10%
In Vivo
11%
Indoleamine 2,3 Dioxygenase
7%
Interleukin 6
6%
Lipopolysaccharide
6%
Lovastatin
7%
Major Depressive Disorder
11%
Memory Disorder
12%
Metabolic Pathway
8%
Microglia
25%
Microtubule
5%
Mitochondrial Function
5%
Mitochondrion
7%
Multiple Sclerosis
19%
Myocardial Infarction
14%
Necrosis
17%
Nervous System Cell
16%
Neuro-Inflammation
7%
Neurodegeneration
28%
Neurodegenerative Disorder
36%
Neurodegenerative Process
5%
Neuronal Cell Death
7%
Neuroprotection
35%
Neuroprotective Agent
20%
Neuroscience
5%
Neutrophil Gelatinase Associated Lipocalin
60%
Nitric Oxide
7%
NMDA Receptor
5%
Oxidative Stress
8%
Parkinson's Disease
7%
Positron Emission Tomography
9%
Postoperative Cognitive Dysfunction
5%
Proinflammatory Cytokine
5%
Protein Kinase B
6%
Protein Kinases
12%
Receptor Subunit
13%
SK Channel
7%
Sleep Pattern
5%
Social Behavior
8%
Spatial Memory
6%
Statin
5%
Synaptic Plasticity
17%
Tau Protein
6%
Tumor Necrosis Factor Alpha
28%
Tumor Necrosis Factor Alpha Receptor
8%
Tumor Necrosis Factor Receptor
44%
Tumor Necrosis Factor Receptor 2
24%
Keyphrases
Age-related
5%
Aging
11%
Alzheimer's Disease
50%
Alzheimer's Disease Model
17%
Alzheimer's Disease Pathology
6%
Alzheimer's Disease Patient
5%
Amyloid-β42
5%
Astrocyte Activation
5%
Behavioral Dysfunction
5%
Beneficial Effects
6%
Brain Diseases
5%
Brain Regions
7%
Cerebrospinal Fluid
7%
Channel Activation
5%
Cognitive Function
5%
Cognitive Performance
6%
Cyclic Adenosine Monophosphate (cAMP)
5%
Depressive Symptoms
5%
Disturbed Sleep
5%
Electroconvulsive Seizure
7%
Electroconvulsive Therapy
7%
Exchange Protein Directly Activated by cAMP
9%
GluA3
7%
Heart Failure
10%
Inflammation
21%
Interleukin-6
6%
Lipocalin 2 (LCN2)
8%
Lovastatin
7%
Major Depressive Disorder
11%
Memory Impairment
5%
Memory Retrieval
6%
Microglia
14%
Mouse Model
10%
Multiple Sclerosis
6%
Myocardial Infarction
10%
Nerve Cells
6%
Neurodegeneration
10%
Neurodegenerative Diseases
17%
Neurodegenerative Processes
5%
Neuroinflammation
23%
Neuropathology
10%
Neuroprotection
12%
Nitric Oxide Regulation
5%
Novel Therapeutics
7%
Protein Kinase B/Akt
6%
Signaling Pathway
5%
Synaptic Plasticity
8%
Therapeutic Strategies
7%
TNF Receptor 1 (TNFR1)
29%
TNF Receptor 2 (TNFR2)
36%
Torpor
7%
Tumor Necrosis Factor-α
24%
Urinary Neutrophil Gelatinase-associated Lipocalin (uNGAL)
23%
Medicine and Dentistry
Alzheimer's Disease
30%
Amyloid
13%
Anti-Inflammatory Drug
6%
Brain Metabolism
7%
Cell Death
9%
Central Nervous System
9%
Cerebellum
5%
Degenerative Disease
7%
Depression
14%
Diet Therapy
5%
Disease
15%
Heart Failure
12%
Multiple Sclerosis
17%
Myocardial Infarction
7%
N(g),n(g) Dimethylarginine
5%
Neurodegeneration
9%
Neurodegenerative Disorder
6%
Neuroinflammation
25%
Neuropathology
6%
Neutrophil Gelatinase Associated Lipocalin
13%
Nitric Oxide
6%
Parkinson's Disease
5%
Positron Emission Tomography
7%
Remyelination
5%
Serositis
8%
Signal Transduction
6%
Spatial Memory
5%
Symptom
6%
Tumor Necrosis Factor
32%
Tumor Necrosis Factor Receptor
23%
Tumor Necrosis Factor Receptor 1
10%
Tumor Necrosis Factor Receptor 2
12%